Global Iodine Contrast Media Market

Iodine Contrast Media Comprehensive Study by Application (Hospitals, Specialty Clinics), Administration (Oral, Injectable, Rectal, Ureteral), Technology (X-Ray, Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Catheterization Laboratory), Indication (Cardiovascular Disorders, Respiratory Diseases, Gastrointestinal Disorders, Nephrological Disorders) Players and Region - Global Market Outlook to 2030

Iodine Contrast Media Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Iodine Contrast Media Market Scope
Iodinated contrast media are iodine-containing contrast agents used in x-ray imaging modalities such as computed tomography (CT). They can also be used in fluoroscopy, angiography, and venography, as well as simple radiography on rare occasions. Despite the fact that iodinated contrast agents are safe and commonly used, they can cause side effects, and concerns about their use, effectiveness, and interactions remain. Some questions are simple to answer, while others necessitate in-depth research. While intravenous administration is the most common, they may also be given by gastrointestinal (oral, rectal), cystourethral, vaginal, intraosseous, and other routes. Contrast agents are familiar to any radiologist, and the number of patients taking these drugs continues to rise as computed tomography (CT) becomes more common.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledGE Healthcare (United States), Bayer AG (Germany), Livealth BioPharma Pvt. Ltd. (India), AMAG pharmaceuticals, Inc. (United States), Bracco Imaging SpA (Italy), Covidien (Ireland), CMC Contrast AB (Sweden), Daiichi Sankyo Company, Limited (Japan), Genovis AB (Sweden) and Guerbet Group (France)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States & Swedish Players will contribute to the maximum growth of Global Iodine Contrast Media market throughout the predicted period.

GE Healthcare (United States), Bayer AG (Germany), Livealth BioPharma Pvt. Ltd. (India), AMAG pharmaceuticals, Inc. (United States), Bracco Imaging SpA (Italy), Covidien (Ireland), CMC Contrast AB (Sweden), Daiichi Sankyo Company, Limited (Japan), Genovis AB (Sweden) and Guerbet Group (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Lantheus Medical Imaging, Inc. (United States), Nanopet Pharma GmbH (Germany), Nanoscan Imaging, LLC (United States), Sanochemia Pharmazeutika AG (Austria), Spago Imaging AB (Sweden), Subhra Pharma Private, Ltd. (India) and Taejoon Pharm Co., Ltd., (South Korea).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Iodine Contrast Media market by Type , by Application (Hospitals and Specialty Clinics) and Region with country level break-up.

On the basis of geography, the market of Iodine Contrast Media has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies

In July, 2018 GE Healthcare launched Omnipaque (iohexol) Oral Solution in United States, Omnipaque is a Ready-To-Drink Iodinated Contrast Medium That Aids in The Diagnosis of Medical Conditions by Improving Diagnostic Visualisation of The Abdominal Gastrointestinal Tract.


Influencing Trend:
Growing Healthcare Infrastructure Due to Pandemic

Market Growth Drivers:
Growing Demand for Image Guided Therapeutics, Prevalence of Cancer Cases and Technical Progress in Imaging Technology

Challenges:
Side Effects and Adverse Reactions and Fierce Competitive Pressure

Restraints:
Brain Damage Due to Radiation Exposure

Opportunities:
Low Penetration in Asian Region

Key Target Audience
Iodine Contrast Media Manufactures, New Entrants and Investors, Iodine Contrast Media Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Application
  • Hospitals
  • Specialty Clinics
By Administration
  • Oral
  • Injectable
  • Rectal
  • Ureteral

By Technology
  • X-Ray
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Catheterization Laboratory

By Indication
  • Cardiovascular Disorders
  • Respiratory Diseases
  • Gastrointestinal Disorders
  • Nephrological Disorders

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Image Guided Therapeutics
      • 3.2.2. Prevalence of Cancer Cases
      • 3.2.3. Technical Progress in Imaging Technology
    • 3.3. Market Challenges
      • 3.3.1. Side Effects and Adverse Reactions
      • 3.3.2. Fierce Competitive Pressure
    • 3.4. Market Trends
      • 3.4.1. Growing Healthcare Infrastructure Due to Pandemic
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Iodine Contrast Media, by Application, Administration, Technology, Indication and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Iodine Contrast Media (Value)
      • 5.2.1. Global Iodine Contrast Media by: Application (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Specialty Clinics
      • 5.2.2. Global Iodine Contrast Media by: Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Injectable
        • 5.2.2.3. Rectal
        • 5.2.2.4. Ureteral
      • 5.2.3. Global Iodine Contrast Media by: Technology (Value)
        • 5.2.3.1. X-Ray
        • 5.2.3.2. Computed Tomography
        • 5.2.3.3. Magnetic Resonance Imaging
        • 5.2.3.4. Ultrasound
        • 5.2.3.5. Catheterization Laboratory
      • 5.2.4. Global Iodine Contrast Media by: Indication (Value)
        • 5.2.4.1. Cardiovascular Disorders
        • 5.2.4.2. Respiratory Diseases
        • 5.2.4.3. Gastrointestinal Disorders
        • 5.2.4.4. Nephrological Disorders
      • 5.2.5. Global Iodine Contrast Media Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Iodine Contrast Media: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GE Healthcare (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Livealth BioPharma Pvt. Ltd. (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. AMAG pharmaceuticals, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bracco Imaging SpA (Italy)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Covidien (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CMC Contrast AB (Sweden)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Daiichi Sankyo Company, Limited (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Genovis AB (Sweden)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Guerbet Group (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Iodine Contrast Media Sale, by Application, Administration, Technology, Indication and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Iodine Contrast Media (Value)
      • 7.2.1. Global Iodine Contrast Media by: Application (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Specialty Clinics
      • 7.2.2. Global Iodine Contrast Media by: Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Injectable
        • 7.2.2.3. Rectal
        • 7.2.2.4. Ureteral
      • 7.2.3. Global Iodine Contrast Media by: Technology (Value)
        • 7.2.3.1. X-Ray
        • 7.2.3.2. Computed Tomography
        • 7.2.3.3. Magnetic Resonance Imaging
        • 7.2.3.4. Ultrasound
        • 7.2.3.5. Catheterization Laboratory
      • 7.2.4. Global Iodine Contrast Media by: Indication (Value)
        • 7.2.4.1. Cardiovascular Disorders
        • 7.2.4.2. Respiratory Diseases
        • 7.2.4.3. Gastrointestinal Disorders
        • 7.2.4.4. Nephrological Disorders
      • 7.2.5. Global Iodine Contrast Media Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Iodine Contrast Media: by Application(USD Million)
  • Table 2. Iodine Contrast Media Hospitals , by Region USD Million (2018-2023)
  • Table 3. Iodine Contrast Media Specialty Clinics , by Region USD Million (2018-2023)
  • Table 4. Iodine Contrast Media: by Administration(USD Million)
  • Table 5. Iodine Contrast Media Oral , by Region USD Million (2018-2023)
  • Table 6. Iodine Contrast Media Injectable , by Region USD Million (2018-2023)
  • Table 7. Iodine Contrast Media Rectal , by Region USD Million (2018-2023)
  • Table 8. Iodine Contrast Media Ureteral , by Region USD Million (2018-2023)
  • Table 9. Iodine Contrast Media: by Technology(USD Million)
  • Table 10. Iodine Contrast Media X-Ray , by Region USD Million (2018-2023)
  • Table 11. Iodine Contrast Media Computed Tomography , by Region USD Million (2018-2023)
  • Table 12. Iodine Contrast Media Magnetic Resonance Imaging , by Region USD Million (2018-2023)
  • Table 13. Iodine Contrast Media Ultrasound , by Region USD Million (2018-2023)
  • Table 14. Iodine Contrast Media Catheterization Laboratory , by Region USD Million (2018-2023)
  • Table 15. Iodine Contrast Media: by Indication(USD Million)
  • Table 16. Iodine Contrast Media Cardiovascular Disorders , by Region USD Million (2018-2023)
  • Table 17. Iodine Contrast Media Respiratory Diseases , by Region USD Million (2018-2023)
  • Table 18. Iodine Contrast Media Gastrointestinal Disorders , by Region USD Million (2018-2023)
  • Table 19. Iodine Contrast Media Nephrological Disorders , by Region USD Million (2018-2023)
  • Table 20. South America Iodine Contrast Media, by Country USD Million (2018-2023)
  • Table 21. South America Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 22. South America Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 23. South America Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 24. South America Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 25. Brazil Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 26. Brazil Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 27. Brazil Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 28. Brazil Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 29. Argentina Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 30. Argentina Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 31. Argentina Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 32. Argentina Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 33. Rest of South America Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 34. Rest of South America Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 35. Rest of South America Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 36. Rest of South America Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 37. Asia Pacific Iodine Contrast Media, by Country USD Million (2018-2023)
  • Table 38. Asia Pacific Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 39. Asia Pacific Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 40. Asia Pacific Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 41. Asia Pacific Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 42. China Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 43. China Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 44. China Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 45. China Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 46. Japan Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 47. Japan Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 48. Japan Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 49. Japan Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 50. India Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 51. India Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 52. India Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 53. India Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 54. South Korea Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 55. South Korea Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 56. South Korea Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 57. South Korea Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 58. Taiwan Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 59. Taiwan Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 60. Taiwan Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 61. Taiwan Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 62. Australia Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 63. Australia Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 64. Australia Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 65. Australia Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 70. Europe Iodine Contrast Media, by Country USD Million (2018-2023)
  • Table 71. Europe Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 72. Europe Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 73. Europe Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 74. Europe Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 75. Germany Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 76. Germany Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 77. Germany Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 78. Germany Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 79. France Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 80. France Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 81. France Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 82. France Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 83. Italy Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 84. Italy Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 85. Italy Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 86. Italy Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 87. United Kingdom Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 88. United Kingdom Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 89. United Kingdom Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 90. United Kingdom Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 91. Netherlands Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 92. Netherlands Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 93. Netherlands Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 94. Netherlands Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 95. Rest of Europe Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 96. Rest of Europe Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 97. Rest of Europe Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 98. Rest of Europe Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 99. MEA Iodine Contrast Media, by Country USD Million (2018-2023)
  • Table 100. MEA Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 101. MEA Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 102. MEA Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 103. MEA Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 104. Middle East Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 105. Middle East Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 106. Middle East Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 107. Middle East Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 108. Africa Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 109. Africa Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 110. Africa Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 111. Africa Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 112. North America Iodine Contrast Media, by Country USD Million (2018-2023)
  • Table 113. North America Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 114. North America Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 115. North America Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 116. North America Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 117. United States Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 118. United States Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 119. United States Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 120. United States Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 121. Canada Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 122. Canada Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 123. Canada Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 124. Canada Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 125. Mexico Iodine Contrast Media, by Application USD Million (2018-2023)
  • Table 126. Mexico Iodine Contrast Media, by Administration USD Million (2018-2023)
  • Table 127. Mexico Iodine Contrast Media, by Technology USD Million (2018-2023)
  • Table 128. Mexico Iodine Contrast Media, by Indication USD Million (2018-2023)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Iodine Contrast Media: by Application(USD Million)
  • Table 140. Iodine Contrast Media Hospitals , by Region USD Million (2025-2030)
  • Table 141. Iodine Contrast Media Specialty Clinics , by Region USD Million (2025-2030)
  • Table 142. Iodine Contrast Media: by Administration(USD Million)
  • Table 143. Iodine Contrast Media Oral , by Region USD Million (2025-2030)
  • Table 144. Iodine Contrast Media Injectable , by Region USD Million (2025-2030)
  • Table 145. Iodine Contrast Media Rectal , by Region USD Million (2025-2030)
  • Table 146. Iodine Contrast Media Ureteral , by Region USD Million (2025-2030)
  • Table 147. Iodine Contrast Media: by Technology(USD Million)
  • Table 148. Iodine Contrast Media X-Ray , by Region USD Million (2025-2030)
  • Table 149. Iodine Contrast Media Computed Tomography , by Region USD Million (2025-2030)
  • Table 150. Iodine Contrast Media Magnetic Resonance Imaging , by Region USD Million (2025-2030)
  • Table 151. Iodine Contrast Media Ultrasound , by Region USD Million (2025-2030)
  • Table 152. Iodine Contrast Media Catheterization Laboratory , by Region USD Million (2025-2030)
  • Table 153. Iodine Contrast Media: by Indication(USD Million)
  • Table 154. Iodine Contrast Media Cardiovascular Disorders , by Region USD Million (2025-2030)
  • Table 155. Iodine Contrast Media Respiratory Diseases , by Region USD Million (2025-2030)
  • Table 156. Iodine Contrast Media Gastrointestinal Disorders , by Region USD Million (2025-2030)
  • Table 157. Iodine Contrast Media Nephrological Disorders , by Region USD Million (2025-2030)
  • Table 158. South America Iodine Contrast Media, by Country USD Million (2025-2030)
  • Table 159. South America Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 160. South America Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 161. South America Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 162. South America Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 163. Brazil Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 164. Brazil Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 165. Brazil Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 166. Brazil Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 167. Argentina Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 168. Argentina Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 169. Argentina Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 170. Argentina Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 171. Rest of South America Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 172. Rest of South America Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 173. Rest of South America Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 174. Rest of South America Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 175. Asia Pacific Iodine Contrast Media, by Country USD Million (2025-2030)
  • Table 176. Asia Pacific Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 177. Asia Pacific Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 178. Asia Pacific Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 179. Asia Pacific Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 180. China Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 181. China Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 182. China Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 183. China Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 184. Japan Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 185. Japan Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 186. Japan Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 187. Japan Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 188. India Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 189. India Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 190. India Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 191. India Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 192. South Korea Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 193. South Korea Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 194. South Korea Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 195. South Korea Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 196. Taiwan Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 197. Taiwan Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 198. Taiwan Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 199. Taiwan Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 200. Australia Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 201. Australia Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 202. Australia Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 203. Australia Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 204. Rest of Asia-Pacific Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 205. Rest of Asia-Pacific Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 206. Rest of Asia-Pacific Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 207. Rest of Asia-Pacific Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 208. Europe Iodine Contrast Media, by Country USD Million (2025-2030)
  • Table 209. Europe Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 210. Europe Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 211. Europe Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 212. Europe Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 213. Germany Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 214. Germany Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 215. Germany Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 216. Germany Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 217. France Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 218. France Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 219. France Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 220. France Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 221. Italy Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 222. Italy Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 223. Italy Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 224. Italy Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 225. United Kingdom Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 226. United Kingdom Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 227. United Kingdom Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 228. United Kingdom Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 229. Netherlands Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 230. Netherlands Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 231. Netherlands Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 232. Netherlands Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 233. Rest of Europe Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 234. Rest of Europe Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 235. Rest of Europe Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 236. Rest of Europe Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 237. MEA Iodine Contrast Media, by Country USD Million (2025-2030)
  • Table 238. MEA Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 239. MEA Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 240. MEA Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 241. MEA Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 242. Middle East Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 243. Middle East Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 244. Middle East Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 245. Middle East Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 246. Africa Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 247. Africa Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 248. Africa Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 249. Africa Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 250. North America Iodine Contrast Media, by Country USD Million (2025-2030)
  • Table 251. North America Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 252. North America Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 253. North America Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 254. North America Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 255. United States Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 256. United States Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 257. United States Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 258. United States Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 259. Canada Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 260. Canada Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 261. Canada Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 262. Canada Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 263. Mexico Iodine Contrast Media, by Application USD Million (2025-2030)
  • Table 264. Mexico Iodine Contrast Media, by Administration USD Million (2025-2030)
  • Table 265. Mexico Iodine Contrast Media, by Technology USD Million (2025-2030)
  • Table 266. Mexico Iodine Contrast Media, by Indication USD Million (2025-2030)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Iodine Contrast Media: by Application USD Million (2018-2023)
  • Figure 5. Global Iodine Contrast Media: by Administration USD Million (2018-2023)
  • Figure 6. Global Iodine Contrast Media: by Technology USD Million (2018-2023)
  • Figure 7. Global Iodine Contrast Media: by Indication USD Million (2018-2023)
  • Figure 8. South America Iodine Contrast Media Share (%), by Country
  • Figure 9. Asia Pacific Iodine Contrast Media Share (%), by Country
  • Figure 10. Europe Iodine Contrast Media Share (%), by Country
  • Figure 11. MEA Iodine Contrast Media Share (%), by Country
  • Figure 12. North America Iodine Contrast Media Share (%), by Country
  • Figure 13. Global Iodine Contrast Media share by Players 2023 (%)
  • Figure 14. Global Iodine Contrast Media share by Players (Top 3) 2023(%)
  • Figure 15. Global Iodine Contrast Media share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 18. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 19. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 21. Livealth BioPharma Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 22. Livealth BioPharma Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 23. AMAG pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. AMAG pharmaceuticals, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Bracco Imaging SpA (Italy) Revenue, Net Income and Gross profit
  • Figure 26. Bracco Imaging SpA (Italy) Revenue: by Geography 2023
  • Figure 27. Covidien (Ireland) Revenue, Net Income and Gross profit
  • Figure 28. Covidien (Ireland) Revenue: by Geography 2023
  • Figure 29. CMC Contrast AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 30. CMC Contrast AB (Sweden) Revenue: by Geography 2023
  • Figure 31. Daiichi Sankyo Company, Limited (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Daiichi Sankyo Company, Limited (Japan) Revenue: by Geography 2023
  • Figure 33. Genovis AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 34. Genovis AB (Sweden) Revenue: by Geography 2023
  • Figure 35. Guerbet Group (France) Revenue, Net Income and Gross profit
  • Figure 36. Guerbet Group (France) Revenue: by Geography 2023
  • Figure 37. Global Iodine Contrast Media: by Application USD Million (2025-2030)
  • Figure 38. Global Iodine Contrast Media: by Administration USD Million (2025-2030)
  • Figure 39. Global Iodine Contrast Media: by Technology USD Million (2025-2030)
  • Figure 40. Global Iodine Contrast Media: by Indication USD Million (2025-2030)
  • Figure 41. South America Iodine Contrast Media Share (%), by Country
  • Figure 42. Asia Pacific Iodine Contrast Media Share (%), by Country
  • Figure 43. Europe Iodine Contrast Media Share (%), by Country
  • Figure 44. MEA Iodine Contrast Media Share (%), by Country
  • Figure 45. North America Iodine Contrast Media Share (%), by Country
List of companies from research coverage that are profiled in the study
  • GE Healthcare (United States)
  • Bayer AG (Germany)
  • Livealth BioPharma Pvt. Ltd. (India)
  • AMAG pharmaceuticals, Inc. (United States)
  • Bracco Imaging SpA (Italy)
  • Covidien (Ireland)
  • CMC Contrast AB (Sweden)
  • Daiichi Sankyo Company, Limited (Japan)
  • Genovis AB (Sweden)
  • Guerbet Group (France)
Additional players considered in the study are as follows:
Lantheus Medical Imaging, Inc. (United States) , Nanopet Pharma GmbH (Germany) , Nanoscan Imaging, LLC (United States) , Sanochemia Pharmazeutika AG (Austria) , Spago Imaging AB (Sweden) , Subhra Pharma Private, Ltd. (India) , Taejoon Pharm Co., Ltd., (South Korea)
Select User Access Type

Key Highlights of Report


Mar 2024 238 Pages 77 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Iodine Contrast Media Market Quantitative research analysis
Global Iodine Contrast Media Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Iodine Contrast Media Market are by end use application [Hospitals and Specialty Clinics].
The Iodine Contrast Media Market is gaining popularity and expected to see strong valuation by 2030.
  • Growing Demand for Image Guided Therapeutics
  • Prevalence of Cancer Cases
  • Technical Progress in Imaging Technology

Know More About Global Iodine Contrast Media Market Report?

Have a Query? Click Here

Other Related Reports

Upper Limb Prosthetics Comprehensive Study by Type (Passive Prosthetic Devices, Body Powered Prosthetic Devices, Myoelectric Prosthetic Devices, Hybrid Prosthetic Devices), End Use (Hospitals, Prosth...
$ 3750
Lupus Erythematosus Treatment Comprehensive Study by Route of Administration (Oral, Intravenous, Subcutaneous), Treatment (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs, Cytotoxic and Imm...
$ 3650
Vesicoureteral Reflux Treatment Comprehensive Study by Type (Primary VUR, Secondary VUR), Treatment (Medicinal Treatment (Antibiotics and Anticholinergics), Minimally Invasive Surgical Treatment), En...
$ 3350
Esophageal Disorders Treatment Comprehensive Study by Application (Hospital Pharmacies, Retail Pharmacy, Drug Stores, Online), Drug Type (Antacids, H2 Blockers, Proton Pump Inhibitors, Prokinetics, O...
$ 3650
Autism Treatment Comprehensive Study by Type (Asperger Syndrome, Pervasive Developmental Disorder, Others), Drugs (SSRIs, Anti-Convulsant, Others), Treatment (Aba, Hyperbaric Oxygen Therapy, Others) ...
$ 3500
Sound Therapy Comprehensive Study by Type (Guided Meditation, Neurologic Music Therapy, Bonny Method, Others), Application (Tinnitus & Hearing, Children & Learning, Emotional & Stress Relief, Brain P...
$ 3650